World's Best Scientists 2026 revealed!
Heiner Wedemeyer

Heiner Wedemeyer

D-Index & Metrics

Microbiology

D-Index
105
Citations
44108
World Ranking
309
National Ranking
20

Medicine

D-Index
108
Citations
49139
World Ranking
5945
National Ranking
337

Overview

Heiner Wedemeyer is affiliated with Hannover Medical School in Germany and has an extensive body of research primarily focused on hepatology within the broader field of medicine. Their work spans numerous aspects of liver disease, including viral hepatitis and liver transplantation.

The scientist's research covers several main topics, which include:

  • Hepatitis C virus research
  • Liver Disease Diagnosis and Treatment
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • Hepatitis Viruses Studies and Epidemiology
  • Liver Diseases and Immunity
  • Organ Transplantation Techniques and Outcomes

Wedemeyer's primary fields of study are within medicine, with subfields concentrating on hepatology, epidemiology, surgery, immunology, and infectious diseases.

Frequent publication venues for Wedemeyer's work include:

  • Journal of Hepatology
  • Zeitschrift für Gastroenterologie
  • Liver International
  • JHEP Reports
  • Journal of Viral Hepatitis

Among recent notable publications authored by Wedemeyer are:

  • "A Phase 3, Randomized Trial of Bulevirtide in Chronic Hepatitis D" (2023) published in New England Journal of Medicine
  • "Safety and efficacy of bulevirtide in combination with tenofovir disoproxil fumarate in patients with hepatitis B virus and hepatitis D virus coinfection (MYR202): a multicentre, randomised, parallel-group, open-label, phase 2 trial" (2022) published in The Lancet Infectious Diseases

Additional recent impactful papers in the broader field, co-authored by others, include:

  • "EASL recommendations on treatment of hepatitis C: Final update of the series" (2020) published in Journal of Hepatology
  • "EASL Clinical Practice Guidelines on hepatitis delta virus" (2023) published in Journal of Hepatology
  • "Prothrombotic immune thrombocytopenia after COVID-19 vaccination" (2021) published in Blood

Heiner Wedemeyer frequently collaborates with other researchers including Markus Cornberg, Benjamin Maasoumy, Katja Deterding, Pietro Lampertico, and Michael P. Manns, who are significant co-authors in related fields of hepatology and liver disease research.

Best Publications

  • Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

    Sarah Blach;Stefan Zeuzem;Michael Manns;Ibrahim Altraif

  • ABT-450/r-Ombitasvir and Dasabuvir with Ribavirin for Hepatitis C with Cirrhosis

    Fred Poordad;Christophe Hezode;Roger Trinh;Kris V. Kowdley

  • EASL recommendations on treatment of hepatitis C: Final update of the series ☆

    Jean-Michel Pawlotsky;Francesco Negro;Alessio Aghemo;Marina Berenguer

  • Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma

    Lars A. Ormandy;Tina Hillemann;Heiner Wedemeyer;Michael P. Manns

  • Sustained Virologic Response and Clinical Outcomes in Patients with Chronic Hepatitis C and Advanced Fibrosis

    Bart J Veldt;E Jenny Heathcote;Heiner Wedemeyer;Juerg Reichen

  • Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma.

    Austin G. Duffy;Susanna V. Ulahannan;Oxana Makorova-Rusher;Osama Rahma

  • Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection

    Heiner Wedemeyer;Xiao Song He;Michelina Nascimbeni;Anthony R. Davis

  • Myeloid Derived Suppressor Cells Inhibit Natural Killer Cells in Patients with Hepatocellular Carcinoma via the NKp30 Receptor

    Bastian Hoechst;Torsten Voigtlaender;Lars Ormandy;Jaba Gamrekelashvili

  • EASL Clinical Practice Guidelines on hepatitis E virus infection

    Harry R. Dalton;Nassim Kamar;Sally A. Baylis;Darius Moradpour

  • Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective.

    Jerzy Jaroszewicz;Jerzy Jaroszewicz;Beatriz Calle Serrano;Karsten Wursthorn;Katja Deterding

  • Hepatitis E virus infection.

    Nassim Kamar;Jacques Izopet;Nicole Pavio;Rakesh Aggarwal

  • Peginterferon plus adefovir versus either drug alone for hepatitis delta.

    Heiner Wedemeyer;Cihan Yurdaydìn;George N. Dalekos;Andreas Erhardt

  • Retreatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin.

    Unknown

  • Epidemiology, pathogenesis and management of hepatitis D: update and challenges ahead

    Heiner Wedemeyer;Michael P. Manns

  • Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

    Stefan Zeuzem;Graham R Foster;Stanley Wang;Armen Asatryan

  • Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report.

    Henry Lik-Yuen Chan;Alex Thompson;Michelle Martinot-Peignoux;Teerha Piratvisuth

  • Long-term efficacy of tenofovir monotherapy for hepatitis B virus-monoinfected patients after failure of nucleoside/nucleotide analogues†

    Florian van Bömmel;Robert A. de Man;Heiner Wedemeyer;Katja Deterding

  • Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study

    Pavel Bogomolov;Alexander Alexandrov;Natalia Voronkova;Maria Macievich

  • Short-term antiviral efficacy of BILN 2061, a hepatitis C virus serine protease inhibitor, in hepatitis C genotype 1 patients.

    Holger Hinrichsen;Yves Benhamou;Heiner Wedemeyer;Markus Reiser

  • Hepatitis delta virus

    Unknown

  • Historical epidemiology of hepatitis C virus (HCV) in selected countries

    P. Bruggmann;T. Berg;A. L. H. Øvrehus;C. Moreno

  • Pathogenesis and treatment of hepatitis e virus infection.

    Heiner Wedemeyer;Sven Pischke;Michael P. Manns

  • Hepatitis E in Germany--an under-reported infectious disease.

    Sven Pischke;Patrick Behrendt;Claus-Thomas Bock;Wolfgang Jilg

Frequent Co-Authors

Michael P. Manns
Michael P. Manns Hannover Medical School
Markus Cornberg
Markus Cornberg Hannover Medical School
Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Christoph Sarrazin
Christoph Sarrazin Goethe University Frankfurt
Hans L. Tillmann
Hans L. Tillmann East Carolina University
Harry L.A. Janssen
Harry L.A. Janssen Erasmus University Rotterdam
Stefan Mauss
Stefan Mauss Université Paris Cité
Sandra Ciesek
Sandra Ciesek Goethe University Frankfurt
Eike Steinmann
Eike Steinmann Ruhr University Bochum
Christian P. Strassburg
Christian P. Strassburg University Hospital Bonn

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring online degrees related to Microbiology can open doors to diverse career opportunities, even for those facing unique challenges. For instance, individuals curious about the best degree for felons highlight accessible programs that provide a fresh start in healthcare and science-related fields.

One promising path is becoming a functional nurse practitioner, blending microbiology knowledge with holistic patient care. This role requires specialized training but offers a dynamic and rewarding career in modern healthcare.

Beyond direct patient care, careers in medical coding and health information management are growing rapidly. Pursuing certification as a certified professional coder salary reflects a lucrative and stable career avenue tied to healthcare data accuracy and compliance.

Similarly, a role as a health information manager salary specialist combines microbiology insights and data management skills to optimize healthcare operations. Online degrees often prepare students for these essential functions, enhancing career flexibility and growth.

Best Scientists Citing Heiner Wedemeyer

Trending Scientists

Recently Published Articles